Edward M. Messing
Affiliations: | University of Rochester, Rochester, NY |
Area:
Molecular Biology, Oncology, Cell BiologyGoogle:
"Edward Messing"Children
Sign in to add trainee| Zaibo Li | grad student | 2002 | Rochester |
| Xi Na | grad student | 2003 | Rochester |
| Dakun Wang | grad student | 2004 | Rochester |
| Xiangrong He | grad student | 2006 | Rochester |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Luo* J, Meng J, Messing EM, et al. (2020) MP79-14 LNCRNA-P21 ALTERS THE ANTIANDROGEN ENZALUTAMIDE-INDUCED PROSTATE CANCER NEUROENDOCRINE DIFFERENTIATION VIA MODULATING THE EZH2/STAT3 SIGNALING The Journal of Urology. 203: e1221 |
| Sathianathen N, Gantz* J, Alarid-Escudero F, et al. (2020) MP73-07 INTRAVESICAL CHEMOTHERAPY FOR LOW GRADE BLADDER CANCER The Journal of Urology. 203: e1123-e1124 |
| Jubber I, Shariat SF, Conroy S, et al. (2019) Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. European Urology |
| Chen J, Chou F, Yeh S, et al. (2019) Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling. Oncogene |
| Huang CP, Chen J, Chen CC, et al. (2019) ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals. Journal of Experimental & Clinical Cancer Research : Cr. 38: 275 |
| Correa AF, Jegede O, Haas NB, et al. (2019) Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900107 |
| Lotan Y, Inman BA, Davis LG, et al. (2019) Evaluation of the UroVysion™ Test to Predict Recurrence and/or Progression of Disease After BCG for Primary High Grade Non-Muscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial. The Journal of Urology. 101097JU000000000000 |
| Leow JJ, Bedke J, Chamie K, et al. (2019) SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer. World Journal of Urology |
| Witthaus M, Truong* M, Gantz J, et al. (2019) MP24-15 MR/US FUSION TARGETED BIOPSY FAILED TO DETECT PROSTATE CANCER: ROLE OF CONFIRMMDX® AS AN ADJUNCT Journal of Urology. 201 |
| Truong* M, Kadiyala V, Osinksi T, et al. (2019) PD17-12 FREQUENCY OF DOWNGRADING FROM MR/US FUSION BIOPSY TO RADICAL PROSTATECTOMY BASED ON ISUP 2014 GRADING MODIFICATIONS Journal of Urology. 201 |